Welcome to LookChem.com Sign In|Join Free

CAS

  • or

2487-48-1

Post Buying Request

2487-48-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

2487-48-1 Usage

Chemical Properties

White Solid

Uses

7β-Hydroxydehydroepiandrosterone (7β-OH DHEA) is the main metabolite of Dehydroepiandrosterone (DHEA) (D229585).

Check Digit Verification of cas no

The CAS Registry Mumber 2487-48-1 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,4,8 and 7 respectively; the second part has 2 digits, 4 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 2487-48:
(6*2)+(5*4)+(4*8)+(3*7)+(2*4)+(1*8)=101
101 % 10 = 1
So 2487-48-1 is a valid CAS Registry Number.

2487-48-1Synthetic route

7β-hydroxy-17-oxoandrost-5-ene-3β-yl acetate

7β-hydroxy-17-oxoandrost-5-ene-3β-yl acetate

5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

Conditions
ConditionsYield
With sodium carbonate In methanol; water for 1.25h; Heating;83%
With water; sodium carbonate In methanol for 3h; Reflux;75%
dehydroepiandrosterone
53-43-0

dehydroepiandrosterone

5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

Conditions
ConditionsYield
With Dipodia gossypina54%
mit Hilfe einer Rhizopus-Art;
With Botryodiplodia malorum In phosphate buffer; dimethyl sulfoxide at 30℃; for 72h; pH=6.0; Microbiological reaction;
dehydroepiandrosterone
53-43-0

dehydroepiandrosterone

A

5-androstene-3β-ol-7,17-dione
566-19-8

5-androstene-3β-ol-7,17-dione

B

3β,7α-dihydroxyandrost-5-ene-17-one
2487-48-1, 7522-54-5, 62357-03-3, 53-00-9

3β,7α-dihydroxyandrost-5-ene-17-one

C

5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

Conditions
ConditionsYield
With Mortierella isabellina AM212 fungal strain for 12h; Enzymatic reaction;A 6%
B 53.5%
C 24%
With Absidia coerulea AM93 In acetone at 20℃; for 8h; Time; Enzymatic reaction;A 5.5%
B 22%
C 49%
dehydroepiandrosterone
53-43-0

dehydroepiandrosterone

A

3β,7α-dihydroxyandrost-5-ene-17-one
2487-48-1, 7522-54-5, 62357-03-3, 53-00-9

3β,7α-dihydroxyandrost-5-ene-17-one

B

5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

Conditions
ConditionsYield
With Aspergillus wentii MRC 200316 In water; N,N-dimethyl-formamide at 27℃; for 120h; pH=7.2; Culture medium; Microbiological reaction; Enzymatic reaction;A 51%
B 12%
With dipotassium hydrogenphosphate; magnesium sulfate heptahydrate; Maltose for 96h; Enzymatic reaction;A 43.6%
B 12.6%
With Mucor racemosus In acetone at 27℃; for 96h;A 40.9%
B 18%
dehydroepiandrosterone
53-43-0

dehydroepiandrosterone

A

3β,7α-dihydroxyandrost-5-ene-17-one
2487-48-1, 7522-54-5, 62357-03-3, 53-00-9

3β,7α-dihydroxyandrost-5-ene-17-one

B

5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

C

3β,5α,6β-trihydroxy-5α-androstan-17-one
10161-36-1

3β,5α,6β-trihydroxy-5α-androstan-17-one

D

3β,11α-dihydroxyandrost-5-en-17-one
39663-17-7

3β,11α-dihydroxyandrost-5-en-17-one

Conditions
ConditionsYield
With Cephalosporium aphidicola In ethanol; dimethyl sulfoxide for 192h;A 31%
B 25%
C 6%
D 6%
dehydroepiandrosterone
53-43-0

dehydroepiandrosterone

A

3β,7α-dihydroxyandrost-5-ene-17-one
2487-48-1, 7522-54-5, 62357-03-3, 53-00-9

3β,7α-dihydroxyandrost-5-ene-17-one

B

5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

C

3β-hydroxy-13,17-secoandrost-5-ene-17,13α-lactone
2061-72-5

3β-hydroxy-13,17-secoandrost-5-ene-17,13α-lactone

D

testololactone
4416-57-3

testololactone

Conditions
ConditionsYield
With Aspergillus tamarii MRC 72400 In N,N-dimethyl-formamide at 25℃; for 120h; Baeyer-Villiger oxidation; Microbiological reaction;A 24%
B 13%
C 28%
D 6%
prasterone acetate
853-23-6

prasterone acetate

A

5-androstene-3β-ol-7,17-dione
566-19-8

5-androstene-3β-ol-7,17-dione

B

3β,7α-dihydroxyandrost-5-ene-17-one
2487-48-1, 7522-54-5, 62357-03-3, 53-00-9

3β,7α-dihydroxyandrost-5-ene-17-one

C

5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

D

3β,14α-dihydroxyandrost-5-en-7,17-dione
58211-52-2

3β,14α-dihydroxyandrost-5-en-7,17-dione

Conditions
ConditionsYield
With Cunninghamella elegans In ethanol for 72h; Further byproducts given;A 5.4%
B 26.8%
C 9%
D 1.1%
With Cunninghamella elegans In ethanol for 72h; Further byproducts given;A 5.4%
B 26.8%
C 9%
D 1.1%
Benzoic acid (3S,7R,8R,9S,10R,13S,14S)-7-isobutyryloxy-10,13-dimethyl-17-oxo-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl ester
188176-04-7

Benzoic acid (3S,7R,8R,9S,10R,13S,14S)-7-isobutyryloxy-10,13-dimethyl-17-oxo-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl ester

5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

Conditions
ConditionsYield
With sodium hydroxide In tetrahydrofuran; methanol at 60℃; for 29h;26%
dehydroepiandrosterone
53-43-0

dehydroepiandrosterone

A

6α-hydroxy-androst-4-ene-3,17-dione
24704-84-5

6α-hydroxy-androst-4-ene-3,17-dione

B

5α-androst-3,6,17-trione
2243-05-2

5α-androst-3,6,17-trione

C

3β,7α-dihydroxyandrost-5-ene-17-one
2487-48-1, 7522-54-5, 62357-03-3, 53-00-9

3β,7α-dihydroxyandrost-5-ene-17-one

D

5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

E

7α-hydroxyandrost-4-ene-3,17-dione
62-84-0, 31427-20-0

7α-hydroxyandrost-4-ene-3,17-dione

F

6β-hydroxy-4-androstene-3,17-dione
63-00-3

6β-hydroxy-4-androstene-3,17-dione

Conditions
ConditionsYield
With Cladosporium sphaerospermum MRC 70266 In water; N,N-dimethyl-formamide at 28℃; for 120h; Enzymatic reaction;A 5%
B 4%
C 20%
D 4%
E 6%
F 15%
dehydroepiandrosterone
53-43-0

dehydroepiandrosterone

A

5-androstene-3β-ol-7,17-dione
566-19-8

5-androstene-3β-ol-7,17-dione

B

3β,7α-dihydroxyandrost-5-ene-17-one
2487-48-1, 7522-54-5, 62357-03-3, 53-00-9

3β,7α-dihydroxyandrost-5-ene-17-one

C

5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

D

3β,7β-dihydroxy-5β,6β-epoxyandrostan-17-one

3β,7β-dihydroxy-5β,6β-epoxyandrostan-17-one

E

3β,4β,7β-trihydroxyandrost-5-en-17-one

3β,4β,7β-trihydroxyandrost-5-en-17-one

F

3β,7α-dihydroxy-5β,6β-epoxyandrostan-17-one

3β,7α-dihydroxy-5β,6β-epoxyandrostan-17-one

G

3β,4β,7α-trihydroxyandrost-5-en-17-one

3β,4β,7α-trihydroxyandrost-5-en-17-one

Conditions
ConditionsYield
With Ulocladium chartarum MRC 72584 In water; N,N-dimethyl-formamide at 28℃; for 120h; Enzymatic reaction;A 6%
B 12%
C 16%
D 3%
E 4%
F 2%
G 3%
3α,5-cyclo-5α-androstan-6β-ol-17-one
663-39-8

3α,5-cyclo-5α-androstan-6β-ol-17-one

A

3β,7α-dihydroxyandrost-5-ene-17-one
2487-48-1, 7522-54-5, 62357-03-3, 53-00-9

3β,7α-dihydroxyandrost-5-ene-17-one

B

5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

C

3β,14α-dihydroxy-androst-5-en-17-one
94991-86-3

3β,14α-dihydroxy-androst-5-en-17-one

D

14α-hydroxy-3α,5-cycloandrostane-6,17-dione

14α-hydroxy-3α,5-cycloandrostane-6,17-dione

Conditions
ConditionsYield
With culture of Cephalosporium aphidicola In ethanol; dimethyl sulfoxide for 192h; Oxidation; hydroxylation; rearrangement; biotransformation; Further byproducts given;A 15%
B 13%
C 6%
D 2%
3α,5-cyclo-5α-androstan-6β-ol-17-one
663-39-8

3α,5-cyclo-5α-androstan-6β-ol-17-one

A

3β,7α-dihydroxyandrost-5-ene-17-one
2487-48-1, 7522-54-5, 62357-03-3, 53-00-9

3β,7α-dihydroxyandrost-5-ene-17-one

B

5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

C

3β,5α,6β-trihydroxy-5α-androstan-17-one
10161-36-1

3β,5α,6β-trihydroxy-5α-androstan-17-one

D

6β,14α-dihydroxy-3α,5-cycloandrostan-17-one
24357-28-6

6β,14α-dihydroxy-3α,5-cycloandrostan-17-one

Conditions
ConditionsYield
With culture of Cephalosporium aphidicola In ethanol; dimethyl sulfoxide for 192h; Oxidation; hydroxylation; rearrangement; biotransformation; Further byproducts given;A 15%
B 13%
C 9%
D 10%
Conditions
ConditionsYield
With dipotassium hydrogenphosphate; magnesium sulfate heptahydrate; Maltose for 96h; Enzymatic reaction;A 8.9%
B 11.1%
prasterone acetate
853-23-6

prasterone acetate

A

5-androstene-3β-ol-7,17-dione
566-19-8

5-androstene-3β-ol-7,17-dione

B

5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

C

5,6β-epoxy-3β,12α-dihydroxy-5β-androstan-17-one
58324-06-4

5,6β-epoxy-3β,12α-dihydroxy-5β-androstan-17-one

D

3β,14α-dihydroxyandrost-5-en-7,17-dione
58211-52-2

3β,14α-dihydroxyandrost-5-en-7,17-dione

Conditions
ConditionsYield
With Cunninghamella elegans In ethanol for 72h; Further byproducts given;A 5.4%
B 9%
C 4.1%
D 1.1%
5-androsten-3β,7β-diol-17-one ethylene ketal 3-tert-butyldimethylsilyl ether
202415-78-9

5-androsten-3β,7β-diol-17-one ethylene ketal 3-tert-butyldimethylsilyl ether

5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

Conditions
ConditionsYield
With hydrogenchloride In tetrahydrofuran; methanol
3β-acetoxy-20-hydroxyiminopregna-5,16-diene
23549-24-8, 23549-26-0, 2174-13-2

3β-acetoxy-20-hydroxyiminopregna-5,16-diene

5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: POCl3; pyridine / toluene / 4 h / 10 - 20 °C
1.2: 51.8 percent / KOH / methanol / Heating
2.1: 18 percent / Mucor racemosus / acetone / 96 h / 27 °C
View Scheme
16-dehydropregnenolone acetate
979-02-2

16-dehydropregnenolone acetate

5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: 87 percent / NH2OH*HCl / pyridine; ethanol; H2O / 0.5 h / Heating
2.1: POCl3; pyridine / toluene / 4 h / 10 - 20 °C
2.2: 51.8 percent / KOH / methanol / Heating
3.1: 18 percent / Mucor racemosus / acetone / 96 h / 27 °C
View Scheme
diosgenin
512-04-9

diosgenin

5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1.1: NH4Cl / pyridine / Heating
1.2: CrO3; CH3COOH / 1,2-dichloro-ethane / 0 °C
1.3: AcONa*3H2O / Heating
2.1: 87 percent / NH2OH*HCl / pyridine; ethanol; H2O / 0.5 h / Heating
3.1: POCl3; pyridine / toluene / 4 h / 10 - 20 °C
3.2: 51.8 percent / KOH / methanol / Heating
4.1: 18 percent / Mucor racemosus / acetone / 96 h / 27 °C
View Scheme
5-androsten-7,17-dione-3β-ol ethylene ketal tert-butyldimethylsilyl ether
202415-77-8

5-androsten-7,17-dione-3β-ol ethylene ketal tert-butyldimethylsilyl ether

5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: NaBH4; CeCl3
2: HCl / methanol; tetrahydrofuran
View Scheme
3β-benzoyloxy-androst-5-en-17-one
83205-52-1, 2080-86-6

3β-benzoyloxy-androst-5-en-17-one

5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

Conditions
ConditionsYield
Multi-step reaction with 8 steps
1: 91 percent / NaBH4 / CH2Cl2 / 2 h / 10 °C
2: 81 percent / pyridine / 48 h / Ambient temperature
3: 68 percent / CrO3, 3,5-dimethylpyrazole / CH2Cl2 / 3 h / -20 °C
4: 83 percent / CeCl3*5H2O, NaBH4 / tetrahydrofuran; methanol / 0.08 h
5: 90 percent / pyridine / 1 h / 0 °C
6: 36 percent / conc. HCl / CHCl3; methanol / 25 h / Ambient temperature
7: 93 percent / Jones reagent / acetone / 0.08 h / Ambient temperature
8: 26 percent / aq. NaOH / tetrahydrofuran; methanol / 29 h / 60 °C
View Scheme
Benzoic acid (3S,8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl ester
96073-67-5

Benzoic acid (3S,8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl ester

5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

Conditions
ConditionsYield
Multi-step reaction with 7 steps
1: 81 percent / pyridine / 48 h / Ambient temperature
2: 68 percent / CrO3, 3,5-dimethylpyrazole / CH2Cl2 / 3 h / -20 °C
3: 83 percent / CeCl3*5H2O, NaBH4 / tetrahydrofuran; methanol / 0.08 h
4: 90 percent / pyridine / 1 h / 0 °C
5: 36 percent / conc. HCl / CHCl3; methanol / 25 h / Ambient temperature
6: 93 percent / Jones reagent / acetone / 0.08 h / Ambient temperature
7: 26 percent / aq. NaOH / tetrahydrofuran; methanol / 29 h / 60 °C
View Scheme
Benzoic acid (3S,8R,9S,10R,13S,14S,17S)-17-acetoxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl ester
188175-90-8

Benzoic acid (3S,8R,9S,10R,13S,14S,17S)-17-acetoxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl ester

5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1: 68 percent / CrO3, 3,5-dimethylpyrazole / CH2Cl2 / 3 h / -20 °C
2: 83 percent / CeCl3*5H2O, NaBH4 / tetrahydrofuran; methanol / 0.08 h
3: 90 percent / pyridine / 1 h / 0 °C
4: 36 percent / conc. HCl / CHCl3; methanol / 25 h / Ambient temperature
5: 93 percent / Jones reagent / acetone / 0.08 h / Ambient temperature
6: 26 percent / aq. NaOH / tetrahydrofuran; methanol / 29 h / 60 °C
View Scheme
Benzoic acid (3S,7R,8R,9S,10R,13S,14S,17S)-17-acetoxy-7-hydroxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl ester
188176-01-4

Benzoic acid (3S,7R,8R,9S,10R,13S,14S,17S)-17-acetoxy-7-hydroxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl ester

5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 90 percent / pyridine / 1 h / 0 °C
2: 36 percent / conc. HCl / CHCl3; methanol / 25 h / Ambient temperature
3: 93 percent / Jones reagent / acetone / 0.08 h / Ambient temperature
4: 26 percent / aq. NaOH / tetrahydrofuran; methanol / 29 h / 60 °C
View Scheme
Benzoic acid (3S,7R,8R,9S,10R,13S,14S,17S)-17-hydroxy-7-isobutyryloxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl ester
188176-03-6

Benzoic acid (3S,7R,8R,9S,10R,13S,14S,17S)-17-hydroxy-7-isobutyryloxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl ester

5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 93 percent / Jones reagent / acetone / 0.08 h / Ambient temperature
2: 26 percent / aq. NaOH / tetrahydrofuran; methanol / 29 h / 60 °C
View Scheme
17β-acetoxy-3β-benzoyloxy-5-androsten-7-one
188176-00-3

17β-acetoxy-3β-benzoyloxy-5-androsten-7-one

5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: 83 percent / CeCl3*5H2O, NaBH4 / tetrahydrofuran; methanol / 0.08 h
2: 90 percent / pyridine / 1 h / 0 °C
3: 36 percent / conc. HCl / CHCl3; methanol / 25 h / Ambient temperature
4: 93 percent / Jones reagent / acetone / 0.08 h / Ambient temperature
5: 26 percent / aq. NaOH / tetrahydrofuran; methanol / 29 h / 60 °C
View Scheme
Benzoic acid (3S,7R,8R,9S,10R,13S,14S,17S)-17-acetoxy-7-isobutyryloxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl ester
188176-02-5

Benzoic acid (3S,7R,8R,9S,10R,13S,14S,17S)-17-acetoxy-7-isobutyryloxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl ester

5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 36 percent / conc. HCl / CHCl3; methanol / 25 h / Ambient temperature
2: 93 percent / Jones reagent / acetone / 0.08 h / Ambient temperature
3: 26 percent / aq. NaOH / tetrahydrofuran; methanol / 29 h / 60 °C
View Scheme
3-O-acetyl-7-oxo-dehydroepiandrosterone
1449-61-2

3-O-acetyl-7-oxo-dehydroepiandrosterone

A

3β,7α-dihydroxyandrost-5-ene-17-one
2487-48-1, 7522-54-5, 62357-03-3, 53-00-9

3β,7α-dihydroxyandrost-5-ene-17-one

B

5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

A

testosterone
58-22-0

testosterone

B

5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

C

Androst-5-ene-3beta,7alpha,17beta-triol
2697-85-0, 62357-04-4, 2226-66-6

Androst-5-ene-3beta,7alpha,17beta-triol

D

5-androstene-3β,7β,17β-triol
2697-85-0

5-androstene-3β,7β,17β-triol

Conditions
ConditionsYield
With water In ethanol for 120h; Microbiological reaction;
5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

1,1,1,3,3,3-hexamethyl-disilazane
999-97-3

1,1,1,3,3,3-hexamethyl-disilazane

3β,7β-bis-(trimethylsiloxy)-5-androsten-17-one
56210-85-6

3β,7β-bis-(trimethylsiloxy)-5-androsten-17-one

Conditions
ConditionsYield
saccharin In acetonitrile for 8h; Reflux; Inert atmosphere; Industry scale;81%
saccharin In acetonitrile for 8h; Reflux; Inert atmosphere;81%
5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

3β,7β-diacetoxyandrost-5-en-17-one
67576-47-0

3β,7β-diacetoxyandrost-5-en-17-one

C24H32O3

C24H32O3

Conditions
ConditionsYield
With scandium tris(trifluoromethanesulfonate) In acetonitrile78%
5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

3β,7β,11α-trihydroxy-5-androsten-17-one
537718-07-3

3β,7β,11α-trihydroxy-5-androsten-17-one

Conditions
ConditionsYield
With Apergillus ochraceus75%
With Aspergillus ochraceus ATCC 18500 (NRRL 405) Microbiological reaction;
5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

N-methoxylamine hydrochloride
593-56-6

N-methoxylamine hydrochloride

dimethylisopropylsilylimidazole
81452-04-2

dimethylisopropylsilylimidazole

(3S,7R,8R,9S,10R,13S,14S)-7-Hydroxy-3-(isopropyl-dimethyl-silanyloxy)-10,13-dimethyl-1,2,3,4,7,8,9,10,11,12,13,14,15,16-tetradecahydro-cyclopenta[a]phenanthren-17-one O-methyl-oxime

(3S,7R,8R,9S,10R,13S,14S)-7-Hydroxy-3-(isopropyl-dimethyl-silanyloxy)-10,13-dimethyl-1,2,3,4,7,8,9,10,11,12,13,14,15,16-tetradecahydro-cyclopenta[a]phenanthren-17-one O-methyl-oxime

Conditions
ConditionsYield
Stage #1: 5-androsten-3β,7β-diol-17-one; N-methoxylamine hydrochloride In pyridine at 60℃; for 1h;
Stage #2: dimethylisopropylsilylimidazole In pyridine at 60℃; for 0.5h;
5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

N-methoxylamine hydrochloride
593-56-6

N-methoxylamine hydrochloride

N-dimethylethylsilyl-imidazole
62365-34-8

N-dimethylethylsilyl-imidazole

(3S,7R,8R,9S,10R,13S,14S)-3-(Ethyl-dimethyl-silanyloxy)-7-hydroxy-10,13-dimethyl-1,2,3,4,7,8,9,10,11,12,13,14,15,16-tetradecahydro-cyclopenta[a]phenanthren-17-one O-methyl-oxime

(3S,7R,8R,9S,10R,13S,14S)-3-(Ethyl-dimethyl-silanyloxy)-7-hydroxy-10,13-dimethyl-1,2,3,4,7,8,9,10,11,12,13,14,15,16-tetradecahydro-cyclopenta[a]phenanthren-17-one O-methyl-oxime

Conditions
ConditionsYield
Stage #1: 5-androsten-3β,7β-diol-17-one; N-methoxylamine hydrochloride In pyridine at 60℃; for 1h;
Stage #2: N-dimethylethylsilyl-imidazole In pyridine at 60℃; for 0.5h;
5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

N-methoxylamine hydrochloride
593-56-6

N-methoxylamine hydrochloride

1-(Trimethylsilyl)imidazole
18156-74-6

1-(Trimethylsilyl)imidazole

(3S,7R,8R,9S,10R,13S,14S)-7-Hydroxy-10,13-dimethyl-3-trimethylsilanyloxy-1,2,3,4,7,8,9,10,11,12,13,14,15,16-tetradecahydro-cyclopenta[a]phenanthren-17-one O-methyl-oxime

(3S,7R,8R,9S,10R,13S,14S)-7-Hydroxy-10,13-dimethyl-3-trimethylsilanyloxy-1,2,3,4,7,8,9,10,11,12,13,14,15,16-tetradecahydro-cyclopenta[a]phenanthren-17-one O-methyl-oxime

Conditions
ConditionsYield
Stage #1: 5-androsten-3β,7β-diol-17-one; N-methoxylamine hydrochloride In pyridine at 60℃; for 1h;
Stage #2: 1-(Trimethylsilyl)imidazole In pyridine at 60℃; for 0.5h;
5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

(1S,2S,4aS,4bR,7S,10R,10aR)-1-Carboxymethyl-7,10-dihydroxy-2,4b-dimethyl-1,2,3,4,4a,4b,5,6,7,8,10,10a-dodecahydro-phenanthrene-2-carboxylic acid

(1S,2S,4aS,4bR,7S,10R,10aR)-1-Carboxymethyl-7,10-dihydroxy-2,4b-dimethyl-1,2,3,4,4a,4b,5,6,7,8,10,10a-dodecahydro-phenanthrene-2-carboxylic acid

Conditions
ConditionsYield
With potassium hydroxide; iodine In methanol; water at 20℃; for 16h;
5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

tert-butyldimethylsilyl chloride
18162-48-6

tert-butyldimethylsilyl chloride

C31H56O3Si2
1016226-91-7

C31H56O3Si2

Conditions
ConditionsYield
With 1H-imidazole In N,N-dimethyl-formamide at 20℃;

2487-48-1Relevant articles and documents

-

Dodson et al.

, p. 6295 (1959)

-

Steroid hydroxylations with Botryodiplodia malorum and Colletotrichum lini

Romano, Andrea,Romano, Diego,Ragg, Enzio,Costantino, Francesca,Lenna, Roberto,Gandolfi, Raffaella,Molinari, Francesco

, p. 429 - 434 (2006)

An improved procedure for the microbial hydroxylations of dehydroepiandrosterone (DHEA, 1) and 15β,16β-methylene-dehydroepiandrosterone (2) was studied using whole cells of Botryodiplodia malorum and Colletotrichum lini. C. lini catalyzed 7α- and 15α-hydroxylation of 1 and 7α-hydroxylation of 2, while B. malorum gave 7β-hydroxylation of both the substrates. The stability of the enzymatic activity was higher in the presence of co-substrates (i.e., glucose or mannitol) allowing for repeated batches of the biotransformations. The yields of 7α,15α-dihydroxy-1 production were improved obtaining 5.8 g l-1 (recovered product) from 7.0 g l-1 of substrate. The structures of the hydroxylated products were assigned by a combination of two-dimensional NMR proton-proton and proton-carbon correlation techniques.

Anti-proliferative action of endogenous dehydroepiandrosterone metabolites on human cancer cell lines.

Yoshida, Shigemasa,Honda, Akira,Matsuzaki, Yasushi,Fukushima, Sugano,Tanaka, Naomi,Takagiwa, Aya,Fujimoto, Yoshinori,Miyazaki, Hiroshi,Salen, Gerald

, p. 73 - 83 (2003)

Dehydroepiandrosterone (DHEA) is a naturally occurring steroid synthesized in the adrenal cortex, gonads, brain, and gastrointestinal tract, and it is known to have chemopreventive and anti-proliferative actions on tumors. These effects are considered to be induced by the inhibition of glucose-6-phosphate dehydrogenase (G6PD) and/or HMG-CoA reductase (HMGR) activities. The present study was undertaken to investigate whether endogenous DHEA metabolites, i.e. DHEA-sulfate, 7-oxygenated DHEA derivatives, androsterone, epiandrosterone, and etiocholanolone, have anti-proliferative effects on cancer cells and to clarify which enzyme, G6PD or HMGR, is responsible for growth inhibition. Growth of Hep G2, Caco-2, and HT-29 cells, evaluated by 3-[4,5-dimethylthiazol]-2yl-2,5-diphenyl tetrazolium bromide (MTT) and bromodeoxyuridine incorporation assays, was time- and dose-dependently inhibited by addition of all DHEA-related steroids we tested. In particular, the growth inhibition due to etiocholanolone was considerably greater than that caused by DHEA in all cell lines. The suppression of growth of the incubated steroids was not correlated with the inhibition of G6PD (r=-0.031, n=9, NS) or HMGR (r=0.219, n=9, NS) activities. The addition of deoxyribonucleosides or mevalonolactone to the medium did not overcome the inhibition of growth induced by DHEA or etiocholanolone, while growth suppression by DHEA was partially prevented by the addition of ribonucleosides. These results demonstrate that endogenous DHEA metabolites also have an anti-proliferative action that is not induced by inhibiting G6PD or HMGR activity alone. These non-androgenic DHEA metabolites may serve as chemopreventive or anti-proliferative therapies.

Microbial transformation of dehydroepiandrosterone (DHEA) by some fungi

Yildirim, Kudret,Kuru, Ali,Y?lmazer Keskin, Semra,Ergin, Sinan

, p. 465 - 474 (2020/11/12)

In this work, biotransformations of dehydroepiandrosterone (DHEA) 1 by Ulocladium chartarum MRC 72584, Cladosporium sphaerospermum MRC 70266 and Cladosporium cladosporioides MRC 70282 have been reported. U. chartarum MRC 72584 mainly hydroxylated 1 at C-7α and C-7β, accompanied by a minor hydroxylation at C-4β, a minor epoxidation from the β-face and a minor oxidation at C-7 subsequent to its hydroxylations. 3β,7β-Dihydroxy-5β,6β-epoxyandrostan-17-one 6, 3β,4β,7α-trihydroxyandrost-5-en-17-one 7 and 3β,4β,7β-trihydroxyandrost-5-en-17-one 8 from this incubation were identified as new metabolites. C. sphaerospermum MRC 70266 converted some of 1 into a 3-keto-4-ene steroid and then hydroxylated at C-6α, C-6β and C-7α, accompanied a minor 5α-reduction and a minor oxidation at C-6 following its hydroxylations. C. sphaerospermum MRC 70266 also hydroxylated some of 1 at C-7α and C-7β. C. cladosporioides MRC 70282 converted almost half of 1 into a 3-keto-4-ene steroid and then hydroxylated at C-6α and C-6β. C. cladosporioides MRC 70282 also reduced some of 1 at C-17.

The generation of a steroid library using filamentous fungi immobilized in calcium alginate Dedicated to the memory of Professor Sir John W. Cornforth, University of Sussex (1917-2013).

Peart, Patrice C.,Reynolds, William F.,Reese, Paul B.

, p. 16 - 24 (2016/01/25)

Four fungi, namely, Rhizopus oryzae ATCC 11145, Mucor plumbeus ATCC 4740, Cunninghamella echinulata var. elegans ATCC 8688a, and Whetzelinia sclerotiorum ATCC 18687, were subjected to entrapment in calcium alginate, and the beads derived were used in the biotransformation of the steroids 3β,17β-dihydroxyandrost-5-ene (1) and 17β-hydroxyandrost-4-en-3-one (2). Incubations performed utilized beads from two different encapsulated fungi to explore their potential for the production of metabolites other than those derived from the individual fungi. The investigation showed that steroids from both single and crossover transformations were typically produced, some of which were hitherto unreported. The results indicated that this general technique can be exploited for the production of small libraries of compounds.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 2487-48-1